Activating and oncogenic GoF mutations in the NOTCH receptors (mostly NOTCH1) typically play a role in promoting later-stage tumor progression but can also act as gatekeepers or lineage-specific driver mutations involved in cancer initiation, such as in T-ALL [43]. The gene discussed is NOTCH1; the disease is neoplasm.